IMCAS on-site booth introducing Hugel products such as HA filler and sutures
Hugel Participates in ‘IMCAS 2025,’ Showcasing the Excellence of HA Fillers and Sutures
Hugel Co., Ltd. participated in the IMCAS World Congress 2025 for the fourth consecutive year, operating an exclusive booth to showcase its HA fillers and suture products. Additionally, Hugel’s Chief Executive Officer Moon Hyung-jin joined a roundtable panel discussion on botulinum toxin, engaging in discussions on the future direction of the market.
IMCAS (International Master Course on Aging Science) is the world’s largest global aesthetic and anti-aging congress. This year’s event was held in Paris, France, from January 30 to February 1, attracting approximately 18,000 industry professionals, including dermatologists and plastic surgeons.
•••
Additionally, the absorbable suture Licellvi (marketed as Blue Rose Forte in Korea) is accelerating its global expansion. Since obtaining its first approval in Thailand in 2023, it has received regulatory approvals in a total of 18 countries, including Europe, Brazil, Bulgaria, and Vietnam.
A Hugel representative stated, “We are delighted to showcase the excellence of Hugel’s products at IMCAS, one of the most prestigious academic events in the medical aesthetics field, for the fourth consecutive year. Moving forward, we will continue to actively engage with medical professionals and industry leaders worldwide to further enhance our corporate value and product competitiveness.”
Copyright © Medical Newspaper. Unauthorized reproduction and redistribution prohibited.
(http://www.bosa.co.kr)
IMCAS on-site booth introducing Hugel products such as HA filler and sutures
Hugel Participates in ‘IMCAS 2025,’ Showcasing the Excellence of HA Fillers and Sutures
Hugel Co., Ltd. participated in the IMCAS World Congress 2025 for the fourth consecutive year, operating an exclusive booth to showcase its HA fillers and suture products. Additionally, Hugel’s Chief Executive Officer Moon Hyung-jin joined a roundtable panel discussion on botulinum toxin, engaging in discussions on the future direction of the market.
IMCAS (International Master Course on Aging Science) is the world’s largest global aesthetic and anti-aging congress. This year’s event was held in Paris, France, from January 30 to February 1, attracting approximately 18,000 industry professionals, including dermatologists and plastic surgeons.
•••
Additionally, the absorbable suture Licellvi (marketed as Blue Rose Forte in Korea) is accelerating its global expansion. Since obtaining its first approval in Thailand in 2023, it has received regulatory approvals in a total of 18 countries, including Europe, Brazil, Bulgaria, and Vietnam.
A Hugel representative stated, “We are delighted to showcase the excellence of Hugel’s products at IMCAS, one of the most prestigious academic events in the medical aesthetics field, for the fourth consecutive year. Moving forward, we will continue to actively engage with medical professionals and industry leaders worldwide to further enhance our corporate value and product competitiveness.”
Copyright © Medical Newspaper. Unauthorized reproduction and redistribution prohibited.
(http://www.bosa.co.kr)